List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 442 studies with search of: "Ritonavir"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/Ritonavir
Condition: Healthy Volunteer
Interventions: Drug: Darunavir;   Drug: Etravirine;   Drug: Ritonavir;   Drug: Lopinavir/ritonavir;   Drug: GSK1349572
2 Completed
Has Results 		Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects
Condition: Human Immunodeficiency Virus Infections
Intervention: Drug: lopinavir/ritonavir (LPV/r) (tablet or capsule) with nucleoside reverse transcriptase inhibitors (NRTIs)
3 Completed Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects
Condition: HIV Infections
Intervention: Drug: Raltegravir plus Darunavir/ritonavir
4 Recruiting Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: Efavirenz;   Drug: Indinavir/ritonavir;   Drug: Nelfinavir;   Drug: Saquinavir/ritonavir;   Drug: Lopinavir/ritonavir;   Drug: Atazanavir;   Drug: Atazanavir/ritonavir;   Drug: Fos-amprenavir/ritonavir;   Drug: Tipranavir/ ritonavir;   Drug: Darunavir/ritonavir
5 Active, not recruiting Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study
Condition: HIV Infections
Interventions: Drug: darunavir, ritonavir, rosuvastatin;   Drug: rosuvastatin, darunavir, ritonavir
6 Completed Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir
Condition: HCV Infection
Interventions: Drug: ABT-450;   Drug: ritonavir;   Drug: Placebo for ABT-450;   Drug: Placebo for ritonavir
7 Completed Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1
Condition: HCV Infection
Interventions: Drug: ABT-450;   Drug: ritonavir;   Drug: placebo for ABT-450;   Drug: Placebo for ritonavir
8 Enrolling by invitation Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses.
Condition: Healthy
Interventions: Drug: Lopinavir/ritonavir 400/100 mg twice daily (2 heat-stable 200/50 mg tablets BID);   Drug: Lopinavir/ritonavir 200/150 mg twice daily;   Drug: Lopinavir/ritonavir 200/50 mg twice daily
9 Terminated A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults
Condition: HIV-1 Infection
Interventions: Drug: Physician determined comparator PI + ritonavir;   Drug: GW640385 + ritonavir
10 Completed Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir
11 Completed Bioequivalence Study of Generic GPO Ritonavir Versus Norvir®
Condition: Healthy
Intervention: Drug: GPO ritonavir versus Norvir
12 Active, not recruiting Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure
Condition: HIV Infections
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Ritonavir;   Drug: GW433908
13 Not yet recruiting Randomised and Prospective Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens
Condition: HIV Infections
Interventions: Drug: Darunavir/ritonavir;   Drug: Lopinavir/ritonavir
14 Completed Efficacy and Safety of Single Versus Double Ritonavir-Boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: ritonavir-boosted PI-based second line treatments;   Drug: two PIs boosted by low dose ritonavir or one PI plus full dose ritonavir
15 Completed Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Atazanavir/Ritonavir;   Drug: Atazanavir/Ritonavir + Famotidine;   Drug: Atazanavir/Ritonavir + Tenofovir Disproxil Fumrarate + Famotidine
16 Completed GSK1349572 Drug Interaction Study With Atazanavir/Ritonavir and Atazanavir
Condition: Healthy Volunteer
Interventions: Drug: GSK1349572;   Drug: Atazanavir 300 mg;   Drug: Atazanavir 400 mg;   Drug: Ritonavir
17 Completed
Has Results 		Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects
Condition: Human Immunodeficiency Virus Infections
Intervention: Drug: lopinavir/ritonavir (LPV/r) tablet with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs)
18 Completed Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir
Condition: HIV Infections
Interventions: Drug: Atazanavir+Ritonavir+Tenofovir;   Drug: Atazanavir+Ritonavir+Tenofovir+Famotidine
19 Completed Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People
Condition: HIV Infections
Interventions: Drug: Fosamprenavir;   Drug: Lopinavir/Ritonavir;   Drug: Ritonavir;   Drug: Tenofovir disoproxil fumarate
20 Not yet recruiting Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects.
Condition: Thrombocytopenia
Interventions: Drug: Eltrombopag and Lopinavir/Ritonavir;   Drug: Lopinavir/Ritonavir;   Drug: Eltrombopag

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services